Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAN pseudogene 9 (RANP9)
- Target
- RANP9
- Molecular classification
- Other (Pseudogene, Non-coding RNA locus if expressed)
01
Overview
RAN pseudogene 9 is classified as a pseudogene—a genomic DNA segment that closely resembles the RAN gene from the RAS oncogene family but does not encode a functional protein[4][3]. Like other pseudogenes, it may be transcriptionally inactive or only transcribed as a non-coding RNA. Some pseudogenes have demonstrated regulatory roles via non-coding RNA mechanisms (such as miRNA sponging or epigenetic modification), but there is no specific evidence of such activity for RANP9. Pseudogenes are mainly of interest for genetic and evolutionary studies and are not considered canonical drug targets[4][3][1][2].
- Other names
- RAN, member RAS oncogene family pseudogene 9RANP9
02
Mechanism of action
null (pseudogenes are not directly targeted by drugs; no mechanisms of action specified for RANP9)
03
Biological functions
Other (pseudogenes may regulate parental gene expression through non-coding RNA mechanisms such as miRNA sponging or epigenetic modulation, but no evidence is available for RANP9 specifically)
04
Disease associations
No published evidence for specific disease associations of RANP9; however, some pseudogenes may broadly play roles in cancer or other diseases via regulatory effects
05
Safety considerations
No safety concerns or therapeutic challenges apply, as it is not a therapeutic target
06
Biomarkers
No evidence for RANP9 as a biomarker; pseudogenes are rarely used as biomarkers outside of a few exceptional cases
Beyond the preview
Go deeper on RAN pseudogene 9 (RANP9).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RAN pseudogene 9 (RANP9).